Immunocompromised hosts, such as individuals undergoing chemotherapy, those with HIV/AIDS, or organ transplant recipients, are particularly vulnerable to infections due to their weakened immune systems. Infectious diseases in immunocompromised hosts can manifest in unusual or severe forms, making diagnosis and treatment more challenging. Opportunistic infections, including fungal, bacterial, and viral pathogens, are common in these patients, and even mild infections can progress rapidly into life-threatening conditions. Effective management requires a careful balance of antimicrobial therapy, immunosuppressive medications, and close monitoring. Additionally, preventative measures, such as vaccinations and hygiene practices, play a critical role in reducing the risk of infections in immunocompromised individuals.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada